Endometrial carcinoma: molecular alterations involved in tumor development and progression

@article{Yeramian2013EndometrialCM,
  title={Endometrial carcinoma: molecular alterations involved in tumor development and progression},
  author={Andr{\'e}e Yeramian and Gema Moreno-Bueno and Xavier Dolcet and Llu{\'i}s Catas{\'u}s and Miguel Abal and Eva Colas and Jaume Revent{\'o}s and Jos{\'e} Palacios and Jaime Prat and Xavier Mat{\'i}as-Guiu},
  journal={Oncogene},
  year={2013},
  volume={32},
  pages={403-413}
}
In the western world, endometrial carcinoma (EC) is the most common cancer of the female genital tract. The annual incidence has been estimated at 10–20 per 100 000 women. Two clinicopathological variants are recognized: the estrogen related (type I, endometrioid) and the non-estrogen related (type II, non-endometrioid).The clinicopathological differences are paralleled by specific genetic alterations, with type I showing microsatellite instability and mutations in phosphatase and tensin… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
55 Citations
87 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 55 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 87 references

Bell DW PIK 3 R 1 ( p 85 a ) is somatically mutated at high frequency in primary endometrial cancer

  • ME Urick, ML Rudd, AK Godwin, D Sgroi, M Merino
  • Cancer Res
  • 2011

Similar Papers

Loading similar papers…